Futura Health Screening is the only ICAVL accredited noninvasive vascular screening program in Washington State. ICAVL (The Intersocietal Commission for the Accreditation of Vascular Laboratories) requires high standards to ensure quality vascular screening exams. Futura Health Screening is a division of Pacific Vascular, Inc, the largest provider of vascular ultrasound testing in the Northwest.
On December 1, 2010 Futura Health Screening attained recognition for its commitment to providing a high level of patient care and quality testing for the diagnosis of vascular disease. Futura achieved accreditation by the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL) in the area of screening, which includes screening for carotid artery disease, peripheral arterial disease (PAD), abdominal aortic aneurysm (AAA), and carotid intima-media thickness (CIMT).
Futura is one of only 39 facilities in United States, Canada, and Puerto Rico that meet or exceed the ICAVL standards for noninvasive vascular screening. During the accreditation process, every aspect of the laboratory’s daily operations and its impact on the quality of health care provided to patients is assessed and reviewed.
Participation in the accreditation process demonstrates the laboratory’s attention to a high level of patient care and quality testing. ICAVL reported that Futura Health Screening has an “excellent screening program with good correlation efforts”.
The ICAVL is a non-profit organization established with the support of eleven medical societies including physicians, technologists and sonographers that represent medical specialties including cardiology, neurology, radiology, vascular medicine, vascular surgery, neurosurgery, internal medicine and biology.
